Search is Powered by Google
Breast Cancer News

Nottingham University Hospital Joins National Trial To Improve Breast Cancer Care For Older Women, UK

Main Category: Breast Cancer
Article Date: 22 Oct 2008 - 5:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:2 and a half stars

2.5 (2 votes)

Health Professional:1 star

1 (1 votes)

Article Opinions: 0 posts

Over half of breast cancers occur in women aged 65 and over and so in a bid to improve treatments and outcomes for women in this age-group, researchers at Nottingham University Hospitals NHS Trust (NUH) have joined a national research trial which will provide fresh hope for millions of women diagnosed with breast cancer.

The multi-centre trial will study the effectiveness of surgery versus 'anti-hormone medications as treatment of early breast cancer in women over 75.

Alongside this trial, researchers from the Breast Institute at NUH and the University of Nottingham will study the biological features of breast cancer, the long-term outcome and impact on quality of life for different treatment options including surgery and drug therapies.

The Nottingham programme is being led by Mr KL Cheung, Clinical Associate Professor/Consultant Breast Surgeon and Clinical Lead for breast cancer services at NUH, and Professors Ian Ellis and Davina Porock from the University of Nottingham.

"NUH is well placed to take an active role in this nation-wide study," explained KL Cheung, "because we have a great deal of experience in developing services specifically aimed at women over 70. When the Nottingham Breast Unit was established some three decades ago, we recognised the need to develop services targeted specifically at women in this age group and we therefore set up a clinic specifically for this group of patients led by consultants and specialist nurses. This service has recently developed into a combined surgical and oncology service with support from Dr DAL Morgan, Consultant Clinical Oncologist."

"This whole programme and the multi-centre study will help us gain a greater understanding of the development of breast cancer in older women and the effectiveness of the various treatments available. We will then be able to improve treatment and services for the majority of women with breast cancer."

Nottingham University Hospitals NHS Trust was named one of the top five teaching Trusts in the UK in the 2007 'Good Hospital Guide' by health information specialist Dr Foster. The guide says that among the key factors of this success were strong partnership working and high quality information. The full guide can be read here.

NUH is one of the largest Trusts in the UK, with an annual budget of more than £630 million. It was formed on 1 April 2006, when two top-rated trusts - Queen's Medical Centre and Nottingham City Hospital - merged in order to develop a range of high-quality, sustainable patient services across the two campuses. As a major teaching Trust, NUH enjoys close links with the city's universities and attracts and develops the highest calibre of staff. It continues to be the hospital of choice for patients, encourage investment and remain at the forefront of research. It has one of the busiest emergency departments in the UK and has over 1,650 hospital beds across both campuses.

NUH


Personalized Homepage Weekly Newsletters Daily News Alerts
Opioid Induced Constipation ADHD Anxiety Asthma Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles All 'How To...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
Understanding And Treating Triple-Negative Breast Cancer
07 Jan 2009
Triple-negative breast cancer is a subtype of breast cancer that is clinically negative for expression of estrogen and progesterone receptors (ER/PR) and HER2 protein. It is characterized by its unique molecular profile...


Treating HER2+ Breast Cancer image Treating HER2+ Breast Cancer

There are at least four different kinds of breast cancer and each is treated differently. For HER2+ breast cancer, a chemotherapy drug is typically the best option. Here's an overview of the drugs used to treat breast cancer...

Breast Cancer Treatment: Get Involved image Breast Cancer Treatment: Get Involved

Today, breast cancer patients may be treated by a multidisciplinary team of specialists, consisting of nurses, oncologists, surgeons, social workers, nutritionists and genetic counselors. However, patients, too, have a critical role in their treatment...

View more videos...